Up­dat­ed: In Fri­day IPO dou­ble­head­er, Apogee and Sagimet help crack open a stuck win­dow on Wall Street

Mark Fri­day, Ju­ly 14, in biotech’s 2023 year­book. Two drug de­vel­op­ers, Apogee Ther­a­peu­tics and Sagimet Bio­sciences, will join the Nas­daq in up­sized of­fer­ings, a pos­i­tive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER